Genetic Testing Registry

Genetic Testing Registry
Name	Genetic Testing Registry
Launched	2016
Owner	National Institutes of Health
Country	United States
Type	biomedical database

Genetic Testing Registry

The Genetic Testing Registry is a publicly accessible repository that cataloged clinical genetic tests and related information. It served as a centralized reference for test descriptions, laboratory contacts, methods, and clinical validity across a spectrum of conditions. The registry operated within an ecosystem of biomedical resources and standards to support clinicians, researchers, and policymakers.

Overview

The registry linked to resources such as National Institutes of Health, National Library of Medicine, ClinicalTrials.gov, PubMed, and GenBank while interfacing with organizations including American College of Medical Genetics and Genomics, World Health Organization, Food and Drug Administration, Centers for Disease Control and Prevention, and National Human Genome Research Institute. It documented tests for conditions cited in publications by authors affiliated with institutions like Johns Hopkins Hospital, Mayo Clinic, Massachusetts General Hospital, Harvard Medical School, and Stanford University School of Medicine. The registry described methodologies referencing standards from International Organization for Standardization, Clinical Laboratory Improvement Amendments, and professional guidance from European Society of Human Genetics.

History and Development

The project emerged in response to initiatives promoted by bodies such as National Institutes of Health, National Human Genome Research Institute, and advisory panels convened with participation from American College of Medical Genetics and Genomics and stakeholders including representatives from National Cancer Institute, Agency for Healthcare Research and Quality, and patient advocacy groups like Genetic Alliance and American Society of Human Genetics. Early development built on data standards used in projects like Human Genome Project, 1000 Genomes Project, and infrastructure from RefSeq and dbSNP. Pilot phases referenced collaborations with academic centers such as University of California, San Francisco, Columbia University Irving Medical Center, and University of Pennsylvania Perelman School of Medicine.

Purpose and Scope

The registry aimed to increase transparency about clinical tests offered by laboratories including those accredited by College of American Pathologists and participating laboratories listed by Clinical Laboratory Improvement Amendments. Its scope covered tests for hereditary disorders, oncology panels, pharmacogenomic assays, and newborn screening panels referenced by agencies such as American Academy of Pediatrics and Advisory Committee on Heritable Disorders in Newborns and Children. The database supported decision-making by clinicians at Cleveland Clinic, researchers at Broad Institute, and policy-makers at Office of the Surgeon General by providing links to evidence in PubMed Central, practice guidelines from National Comprehensive Cancer Network, and variant interpretations from resources like ClinVar.

Data Submission and Curation

Laboratories and submitters followed data models influenced by projects like Sequence Read Archive and data exchange formats used by Global Alliance for Genomics and Health. Submission workflows referenced identifiers such as those from National Provider Identifier systems and catalogs maintained by Centers for Medicare & Medicaid Services. Curation involved expert panels and annotation practices akin to those employed by ClinGen and Human Phenotype Ontology consortia, and workflows cross-referenced clinical variant evidence appearing in Nature Genetics, The New England Journal of Medicine, and Science Translational Medicine.

Access, Use, and Privacy

Access policies paralleled standards from Health Insurance Portability and Accountability Act, guidance from Office for Human Research Protections, and data-sharing frameworks advocated by Global Alliance for Genomics and Health and International Committee of Medical Journal Editors. Privacy considerations intersected with case law and policy influenced by institutions such as Department of Health and Human Services and ethics guidance from Presidential Commission for the Study of Bioethical Issues. Use cases addressed clinical decision support at hospitals like Seattle Children’s Hospital and incorporation into electronic records systems by vendors such as Epic Systems and Cerner.

Impact and Applications

The registry informed test selection in oncology programs at MD Anderson Cancer Center and hereditary cancer clinics at Memorial Sloan Kettering Cancer Center, supported pharmacogenomics projects at Veterans Health Administration, and aided newborn screening discussions in collaborations with March of Dimes. Researchers used registry metadata to map assay availability for consortia like All of Us Research Program and comparative studies published in journals such as Genetics in Medicine and PLOS Genetics. Public health agencies, academic centers, and patient advocacy organizations referenced the registry when developing screening policies or conducting systematic reviews.

Governance and Criticism

Governance structures drew on models from National Institutes of Health, advisory input from American College of Medical Genetics and Genomics, and interactions with regulatory agencies including Food and Drug Administration and Federal Trade Commission on laboratory marketing and oversight. Criticism focused on concerns raised in commentary from stakeholders at American Civil Liberties Union, researchers publishing in The BMJ, and policy analysts affiliated with Brookings Institution regarding completeness, data standardization, and potential commercial use. Debates involved academic groups at Yale School of Medicine and think tanks like RAND Corporation about transparency, sustainability, and integration with clinical workflows.

Category:Genetics databases